Luliya Cream contains Luliconazole 1% w/w, an imidazole antifungal agent indicated for the topical treatment of superficial fungal infections of the skin. Luliconazole exhibits broad-spectrum antifungal activity against dermatophytes, yeasts, and molds by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, thereby disrupting membrane integrity and leading to fungal cell death. Luliya Cream is primarily used in the management of tinea infections such as tinea corporis, tinea cruris, and tinea pedis. The formulation is designed for once-daily application, promoting patient compliance and effective treatment outcomes. Clinical studies have demonstrated Luliconazole’s superior efficacy and rapid onset of action compared to other topical antifungals, with minimal adverse effects. Common side effects may include mild local irritation, itching, or redness at the application site, which are generally transient. Luliya Cream should be applied to the affected area and surrounding skin after cleansing and drying, avoiding contact with eyes and mucous membranes. It is contraindicated in patients with known hypersensitivity to Luliconazole or any excipients in the formulation. Use during pregnancy and lactation should be under medical supervision. Luliya Cream offers a reliable therapeutic option for effective management of superficial fungal infections.